Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Pregabalin 150 mg capsules vs Lyrica 150 mg capsules in healthy Thai volunteers under fasting
TCTR20211126005Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pregabalin (2 arms), sponsored by Bio-innova. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
pregabalin
Beyond the preview
Go deeper on TCTR20211126005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211126005.